TARGETED MEDICINES BY DESIGN

MDS Inc.

Application Filed: 2004-01-26

Trademark Application Details

Status

602

Dead/Abandoned

ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE

Research	OneLook Acronym Finder
Serial Number	78357607
Mark Drawing Code	3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Domestic Representative	Merchant & Gould P.C.
Attorney Name	John A. Clifford
Attorney Docket Number	07297.0442US
Law Office Assigned	M10
Employee Name	THOMAS, AMY E

Timeline

2004-01-26	Application Filed
2006-03-28	Abandon
2006-04-25	Location: TMO LAW OFFICE 110 - EXAMINING ATTORNEY ASSIGNED
2006-04-25	Status: Dead/Abandoned
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	MDS Inc.
Address	100 International Boulevard Toronto CA M9W 6J6
Legal Entity Type	Corporation
Legal Entity State	CA

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Design Search Codes

241525	Other arrows
261713	Letters or words underlined and/or overlined by one or more strokes or lines; Overlined words or letters; Underlined words or letters

Attorney of Record

John A. Clifford
Merchant & Gould P.C.
P. O. Box 2910
Minneapolis, MN 55402

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052
International Codes:	42
U.S. Codes:	100,101

Type Code	Type
GS0051	Pharmaceutical preparations for the treatment of radioimmune diseases, namely radloimmunotherapeutics; pharmaceutical preparations in the nature of drug antibody and toxin-antibody conjugates for the purpose of removing and fighting toxins in the body; pharmaceutical preparations in the nature of targeted therapeutics for the diagnosis, therapy and/or prevention of human conditions or disease, namely for use in the treatment of cancer, specifically blood borne cancers and solid tumors; pharmaceutical preparations in the nature of drug delivery agents consisting compounds that facilitate delivery of a wide range of pharmaceuticals comprised of proteins, peptides, peptidomimetics, lipids, carbohydrates, nucleic acids, aptamers, and/or synthetic organic molecules, that selectively bind to any human or bacterial cell, any cell type, any fungus, any virus, any human pathogen, or any component of the above, including fragments and semi-synthetic derivatives

Type Code

Type

GS0051

Pharmaceutical preparations for the treatment of radioimmune diseases, namely radloimmunotherapeutics; pharmaceutical preparations in the nature of drug antibody and toxin-antibody conjugates for the purpose of removing and fighting toxins in the body; pharmaceutical preparations in the nature of targeted therapeutics for the diagnosis, therapy and/or prevention of human conditions or disease, namely for use in the treatment of cancer, specifically blood borne cancers and solid tumors; pharmaceutical preparations in the nature of drug delivery agents consisting compounds that facilitate delivery of a wide range of pharmaceuticals comprised of proteins, peptides, peptidomimetics, lipids, carbohydrates, nucleic acids, aptamers, and/or synthetic organic molecules, that selectively bind to any human or bacterial cell, any cell type, any fungus, any virus, any human pathogen, or any component of the above, including fragments and semi-synthetic derivatives

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2004-02-04	1 NWAP I:Incoming Correspondence
ASSIGNED TO EXAMINER	2004-08-18	2 DOCK D:Assigned to Examiner
NON-FINAL ACTION MAILED	2004-08-19	3 CNRT F:First Action
PAPER RECEIVED	2005-02-25	4 MAIL I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE	2005-02-25	5 CRFA I:Incoming Correspondence
AMENDMENT FROM APPLICANT ENTERED	2005-03-11	6 ACEC I:Incoming Correspondence
SUSPENSION LETTER WRITTEN	2005-03-13	7 CNSL R:Renewal
LETTER OF SUSPENSION MAILED	2005-03-14	8 CNSL S:
LIE CHECKED SUSP - TO ATTY FOR ACTION	2005-09-24	9 RCCK S:
SUSPENSION INQUIRY WRITTEN	2005-09-27	10 CNSI R:Renewal
INQUIRY AS TO SUSPENSION MAILED	2005-09-27	11 CNSI S:
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE	2006-04-25	12 ABN2 O:Outgoing Correspondence
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND	2006-04-25	13 MAB2 O:Outgoing Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.